At 4.8% CAGR, North America Intermittent Catheters Market is Projected to be Worth US$ 1,506.64 Million by 2031, says Business Market Insights

According to Business Market Insights' research, the North America intermittent catheters market was valued at US$ 1,035.79 million in 2023 and is expected to reach US$ 1,506.64 million by 2031, registering a CAGR of 4.8% from 2023 to 2031. Micro-hole zone catheters and adoption of single-use catheters are among the critical factors attributed to drive the North America intermittent catheters market growth.

UTIs are common complications associated with intermittent catheterization (CIC), which hampers individuals' quality of life and adds to their healthcare expenditures. Residual urine, presumably related to the intermittent catheter's design, has been found as one of several risk factors for infections. Micro-hole zone catheters (MHZCs) have been developed to address the issue of incomplete bladder emptying. MHZCs include a drainage zone with multiple micro-holes from the tip and extending down the catheter's tube, contrary to conventional eyelet catheters (CEC) that typically have two drainage eyelets by the catheter tip. Micro-hole drainage zone catheters are claimed to reduce the probability of early flow stoppages in intermittent catheter users. As a result, the drainage is typically unbroken, ensuring bladder emptying regardless of the user's approach. Further, avoiding mucosal suctions eliminates the need for catheter repositioning and lowers the risk of mucosal microtrauma. In February 2023, Coloplast introduced Luja, a new catheter for males that redefines bladder emptying. Luja's unique design facilitates complete bladder emptying in a single free flow and represents a paradigm shift within intermittent catheterization. Thus, the advantages related to micro-hole intermittent catheters are expected to bring new intermittent catheter market trends in the coming years.

On the contrary, complications associated with catheterization hamper the growth of North America intermittent catheters market.

By product, the North America intermittent catheters market is segmented into coated intermittent catheters and uncoated intermittent catheters. The coated intermittent catheters segment held 63.0% share of North America intermittent catheters market share in 2023, amassing US$ 652.70 million. It is projected to garner US$ 967.07 million by 2031 to register 5.0% CAGR during 2023-2031.

In terms of indication, the North America intermittent catheters market is segmented into urinary incontinence, general surgeries, spinal cord injuries, Parkinson's Disease (PD), multiple sclerosis, and others. The urinary incontinence segment held 52.5% share of North America intermittent catheters market share in 2023, amassing US$ 544.13 million. It is projected to garner US$ 800.09 million by 2031 to register 4.9% CAGR during 2023-2031.

Based on category, the North America intermittent catheters market is categorized into female length catheters, male length catheters, and kid length catheters. The female length catheters segment held 70.8% share of North America intermittent catheters market share in 2023, amassing US$ 733.78 million. It is projected to garner US$ 1,092.60 million by 2031 to register 5.1% CAGR during 2023-2031.

By system type, the North America intermittent catheters market is bifurcated into closed intermittent catheters systems and open intermittent catheters systems. The closed intermittent catheters segment held 65.3% share of North America intermittent catheters market share in 2023, amassing US$ 676.53 million. It is projected to garner US$ 1,007.70 million by 2031 to register 5.1% CAGR during 2023-2031.

In terms of end user, the North America intermittent catheters market is segmented into hospitals, ambulatory surgical centers, home care settings, and others. The hospitals segment held 45.2% share of North America intermittent catheters market share in 2023, amassing US$ 468.64 million. It is projected to garner US$ 655.62 million by 2031 to register 4.3% CAGR during 2023-2031.

Based on country, the North America intermittent catheters market is categorized into the US, Canada, and Mexico. Our regional analysis states that the US captured 83.4% share of North America intermittent catheters market in 2023. It was assessed at US$ 863.85 million in 2023 and is likely to hit US$ 1,269.28 million by 2031, registering a CAGR of 4.9% during 2023-2031.

Key players operating in the North America intermittent catheters market are Advin Health Care Pvt Ltd; B Braun SE; Boston Scientific Corp; Cardinal Health Inc; Coloplast Corp; Convatec Group Plc; Hollister Inc; Medical Technologies of Georgia, Inc.; Teleflex Inc; and Wellspect HealthCare, among others.

- In April, 2024: Wellspect HealthCare launched LoFric Origo Sleeve, a new line extension to its LoFric Origo catheter range. The new product is part of company's LoFric Origo range. The product features a non-touch technique, including a thin cover that runs along the catheter tube. It forms a protective sleeve that allows for more hygienic handling.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com